Introduction

This in-depth 2 day event will detail the journey of neuroscience discovery from initial lead through to clinical trials, bringing together leading companies for discussion, knowledge-sharing and focused networking.

Track 1: Therapeutic Strategies, Enabling Technologies & Biomarker Development 

• Advancements and emerging trends in the application of technology in developing neurological treatments 
• Neuroscience biomarker development 
• Translational approaches for drug discovery 
• Opportunities and challenges of designing and implementing targeted diagnostics and therapeutics 
• Diagnostic tool development

Track 2: Drug Discovery for Neurodegenerative Diseases 

• Target identification and validation approaches 
• Stem cell technology to fuel drug discovery 
• iPS cells for disease modelling and drug discovery 
• Blood brain barrier in CNS drug discovery 
• Assay Development & Screening 
• In vitro and in vivo disease modelling 
• The role of informatics in CNS drug discovery 

Useful links

• Further event details More information about the event

Speakers

• Sebastien Gillotin MSD, United Kingdom
• Pekka Kallunki Lundbeck, Denmark
• Iain Chessell AstraZeneca, United Kingdom
• Ludovic Collin Switzerland
• Magnus Walter AbbVie, United Kingdom
• Jenny Barnett Monument Therapeutics, United Kingdom

---

Venue

Maritim proArte Hotel Berlin

Maritim proArte Hotel Berlin, Friedrichstrasse 151/ Dorotheenstrasse 65 (Navigation address), Berlin, 10117 , Germany

Useful links

• Venue information More information about the venue

Committee

• Oxford Global United Kingdom

  https://www.oxfordglobal.co.uk/

---

Organised by

Oxford Global

Oxford Global

Contact information

Harry Liddiard
Oxford Global
+441865248455
Contact us by email

---